4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-026737
Chief Development Officer sold 8,000 shares at $14.51 ($116,080)
- Chief Development Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Michaelson Jennifer · Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-25 | Exercise or conversion : show line 1 in the form | +8,000 | $4.30 | $34,400 | 61,031 | D |
| 2022-07-25 | Sale : show line 2 in the form | −8,000 | $14.51 | $116,080 | 53,031 | D |
| Open-market sales · 8,000 sh · avg $14.51 · $116,080 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-07-25 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −8,000 | 209,978 | D |
Loading xslF345X03/doc4.xml…